艾美疫苗股份有限公司（下称“艾美疫苗”）于2026年3月3日刊发2026年2月股份变动月报表。报告期为2026年2月28日。该公司在中华人民共和国注册成立，其在香港联交所上市的股票代码为06660。
报告显示，艾美疫苗注册股本为人民币1,226,562,599元，涵盖507,673,711股H股和718,888,888股内资股。截至2月28日，各类股本数量保持不变：H股与内资股分别为507,673,711股和718,888,888股，均无新增发行、购回或注销活动。公司已发行股份总数截至月末维持在1,226,562,599股。
另据公告，报告期内无股份期权、可换股票据或其他协议项下导致的股份变动事项；公司申明已符合香港联交所相关上市规则及法规就公众持股比例的要求。该月报经公司秘书刘灵签署。公司同时确认，所有证券的发行及上市事宜均遵循现行法律及监管规定，股本结构维持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.